CCL
64
-6
VLO
26
3
SYY
41
-2
GME
63
2
REGN
44
2
MAC
51
-2
IVZ
48
6
FFIV
63
2
NWS
75
4
ABBV
46
4
KLAC
56
11
PGR
49
4
XEL
51
3
NAVI
33
-8
WFC
60
2
UNH
44
2
AA
31
4
SJM
19
2
WU
24
-2
NVDA
57
5
CCL
64
-6
VLO
26
3
SYY
41
-2
GME
63
2
REGN
44
2
MAC
51
-2
IVZ
48
6
FFIV
63
2
NWS
75
4
ABBV
46
4
KLAC
56
11
PGR
49
4
XEL
51
3
NAVI
33
-8
WFC
60
2
UNH
44
2
AA
31
4
SJM
19
2
WU
24
-2
NVDA
57
5
Financhill
Back

abrdn Life Sciences Investors Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36

HQL
abrdn Life Sciences Investors

Last Price:
$13.63
Seasonality Move:
4.03%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

abrdn Life Sciences Investors Stock Forecast

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 3.1% based on the past 26 years of stock performance.
  • abrdn Life Sciences Investors has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%
  • Is abrdn Life Sciences Investors Stock Undervalued?
    The current abrdn Life Sciences Investors [HQL] share price is $13.47. The Score for HQL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • HQL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will abrdn Life Sciences Investors Stock Go Up Next Year?

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 3.1% based on the past 26 years of stock performance.

abrdn Life Sciences Investors Stock Rating

Sell
36
abrdn Life Sciences Investors (HQL) is a Sell

Is abrdn Life Sciences Investors overpriced?

  • abrdn Life Sciences Investors has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%

abrdn Life Sciences Investors Stock Price History

Is HQL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Sector:
Type:
stock
Website:
abrdnhql.com

52-Week Data

52-Week High:
15.90
52-Week Low:
12.76

Prediction Charts

Market Cap:
0
Price in USD:
13.47
Volume:
145.9K
Beta:
0.95

Technical Analysis

SMA50:
14.44
SMA100:
14.80
SMA200:
14.33
52-Wk Change:
0.75%

Stock Predictions

  • Is abrdn Life Sciences Investors stock public?
    Yes, abrdn Life Sciences Investors is a publicly traded company.
  • What is the abrdn Life Sciences Investors stock quote today?
    The abrdn Life Sciences Investors stock price is 13.47 USD today.
  • How to buy abrdn Life Sciences Investors stock online?
    You can buy abrdn Life Sciences Investors shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-4 14.31 14.23 14.36 14.19
Dec-5 14.33 14.22 14.36 14.16
Dec-6 14.27 14.28 14.33 14.25
Dec-9 14.37 14.32 14.45 14.28
Dec-10 14.34 14.16 14.38 14.15
Dec-11 14.19 14.19 14.27 14.10
Dec-12 14.12 13.98 14.12 13.96
Dec-13 13.97 13.84 13.97 13.81
Dec-16 13.89 13.80 13.96 13.76
Dec-17 13.86 13.87 13.90 13.81
Dec-18 13.87 13.34 13.92 13.34
Dec-19 13.40 13.15 13.53 13.11
Dec-20 13.16 13.50 13.54 13.16
Dec-23 13.50 13.47 13.53 13.34

abrdn Life Sciences Investors Earnings

Data Unavailable

abrdn Life Sciences Investors Forecast Revenue Growth

Data Unavailable

* abrdn Life Sciences Investors stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.